Published in Int Psychogeriatr on June 14, 2013
Depressive symptoms in neurodegenerative diseases. World J Clin Cases (2015) 0.77
Outcome measures for Parkinson's disease dementia: a systematic review. Mov Disord Clin Pract (2015) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Intraclass correlations: uses in assessing rater reliability. Psychol Bull (1979) 71.07
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
A new clinical scale for the staging of dementia. Br J Psychiatry (1982) 21.77
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology (1994) 21.65
The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry (1982) 10.83
Measurement of functional activities in older adults in the community. J Gerontol (1982) 10.07
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Cornell Scale for Depression in Dementia. Biol Psychiatry (1988) 6.61
Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res (1991) 4.30
A description of agitation in a nursing home. J Gerontol (1989) 2.81
Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry (2009) 2.16
Neuropsychiatric symptoms in Alzheimer's disease. Alzheimers Dement (2011) 1.81
Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci (2003) 1.67
The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry (2002) 1.59
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis. Int J Geriatr Psychiatry (2008) 1.51
Aggressive course of disease in dementia. Alzheimers Dement (2006) 1.44
Management of behavioral problems in Alzheimer's disease. Int Psychogeriatr (2010) 1.38
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord (2007) 1.38
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. Int J Geriatr Psychiatry (2001) 1.12
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr (2010) 1.08
Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum. Dement Geriatr Cogn Disord (2012) 1.07
Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity. Am J Geriatr Psychiatry (2006) 1.06
Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord (2009) 0.99
Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry (1999) 0.99
Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes. Int Psychogeriatr (2010) 0.98
Reliability of the Brazilian Portuguese version of the Neuropsychiatric Inventory (NPI) for patients with Alzheimer's disease and their caregivers. Int Psychogeriatr (2008) 0.94
REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease. CNS Neurosci Ther (2010) 0.94
Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry (2012) 0.90
Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. Am J Geriatr Psychiatry (2005) 0.89
Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study. Int J Geriatr Psychiatry (2009) 0.89
Disruptive vocalization and depression in older nursing home residents. Int Psychogeriatr (2000) 0.82
Apathy and depression in mild Alzheimer's disease: a cross-sectional study using diagnostic criteria. J Alzheimers Dis (2012) 0.82
Patterns of neuropsychiatric sub-syndromes in Brazilian and Norwegian patients with dementia. Int Psychogeriatr (2012) 0.78
Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes. Alzheimers Dement (2012) 0.77
Validation of the Brazilian version of the apathy inventory. Int J Geriatr Psychiatry (2013) 0.76
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2003) 3.79
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008) 3.48
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry (2004) 2.82
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol (2006) 2.71
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry (2005) 2.61
Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry (2002) 2.52
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry (2009) 2.16
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc (2004) 2.01
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry (2010) 1.83
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry (2011) 1.83
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry (2013) 1.80
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
Exercise and mental health: many reasons to move. Neuropsychobiology (2009) 1.68
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry (2015) 1.65
The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sex Transm Dis (2004) 1.65
Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am J Epidemiol (2002) 1.64
Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry (2015) 1.62
The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. J Am Med Dir Assoc (2008) 1.61
A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry (2011) 1.61
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimers Dement (2013) 1.51
Epidemiology of apathy in older adults: the Cache County Study. Am J Geriatr Psychiatry (2007) 1.50
Race and restless legs syndrome symptoms in an adult community sample in east Baltimore. Sleep Med (2006) 1.48
Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry (2012) 1.47
Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J Neuropsychiatry Clin Neurosci (2008) 1.46
The persistence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2004) 1.46
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc (2014) 1.35
Serum sphingomyelins and ceramides are early predictors of memory impairment. Neurobiol Aging (2008) 1.35
Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci (2009) 1.33
Citalopram for agitation in Alzheimer's disease: design and methods. Alzheimers Dement (2012) 1.31
The association of neuropsychiatric symptoms and environment with quality of life in assisted living residents with dementia. Gerontologist (2005) 1.30
Design of Depression in Alzheimer's Disease Study-2. Am J Geriatr Psychiatry (2006) 1.24
Predictors of functional impairment in residents of assisted-living facilities: the Maryland Assisted Living study. J Gerontol A Biol Sci Med Sci (2005) 1.22
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement (2010) 1.20
Systematic review of the effectiveness of non-pharmacological interventions to improve quality of life of people with dementia. Int Psychogeriatr (2012) 1.20
Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry (2003) 1.19
The incidence of mental and behavioral disturbances in dementia: the cache county study. J Neuropsychiatry Clin Neurosci (2003) 1.18
Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry (2008) 1.17
Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial. Int J Geriatr Psychiatry (2011) 1.16
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry (2004) 1.13
Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets? Neuromolecular Med (2010) 1.12
Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry (2011) 1.11
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement (2012) 1.11
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry (2010) 1.11
Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc (2005) 1.10
The fornix sign: a potential sign for Alzheimer's disease based on diffusion tensor imaging. J Neuroimaging (2011) 1.10
Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis (2011) 1.10
Physical exercise and clinically depressed patients: a systematic review and meta-analysis. Neuropsychobiology (2013) 1.08
Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease. Front Neurol (2011) 1.06
Influence of social network characteristics on cognition and functional status with aging. Int J Geriatr Psychiatry (2008) 1.04
A randomized, controlled, clinical trial of activity therapy for apathy in patients with dementia residing in long-term care. Int J Geriatr Psychiatry (2004) 1.03
Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease. Eur Arch Psychiatry Clin Neurosci (2008) 1.03
Correlates of caregiver-rated quality of life in assisted living: the Maryland Assisted Living study. J Gerontol B Psychol Sci Soc Sci (2006) 1.03
Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study. Am J Geriatr Psychiatry (2012) 1.03
DTI analyses and clinical applications in Alzheimer's disease. J Alzheimers Dis (2011) 1.02
A clinical approach to mild cognitive impairment. Am J Psychiatry (2006) 1.02
Different patterns of white matter degeneration using multiple diffusion indices and volumetric data in mild cognitive impairment and Alzheimer patients. PLoS One (2012) 1.01
Rapidly progressive dementias and the treatment of human prion diseases. Expert Opin Pharmacother (2010) 1.00
Antipsychotic drugs in dementia: what should be made of the risks? JAMA (2005) 0.99
Caregiver coping strategies predict cognitive and functional decline in dementia: the Cache County Dementia Progression Study. Am J Geriatr Psychiatry (2013) 0.99
Quality of life among elderly patients with dementia in institutions. Dement Geriatr Cogn Disord (2011) 0.98
Delusions and hallucinations in Alzheimer's disease: review of the brain decade. Psychosomatics (2003) 0.98
Mild cognitive impairment: cognitive screening or neuropsychological assessment? Rev Bras Psiquiatr (2008) 0.97
White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother (2013) 0.96
Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc (2010) 0.96
Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'. Int J Geriatr Psychiatry (2005) 0.96
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Apolipoprotein E genotype and lifetime cognitive decline. Int Psychogeriatr (2007) 0.95
Epidemiology, assessment, and treatment of dementia. Psychiatr Clin North Am (2011) 0.94
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma. J Alzheimers Dis (2010) 0.94
Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci (2003) 0.94
Quality of life of community-residing persons with dementia based on self-rated and caregiver-rated measures. Qual Life Res (2011) 0.94
Predictors of providing informed consent or assent for research participation in assisted living residents. Am J Geriatr Psychiatry (2008) 0.94
Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS. Int J Geriatr Psychiatry (2006) 0.94
Sleep disturbances in the elderly residing in assisted living: findings from the Maryland Assisted Living Study. Int J Geriatr Psychiatry (2005) 0.93
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry (2012) 0.93
Neuropsychological tests and driving in dementia: a review of the recent literature. Rev Assoc Med Bras (2009) 0.93
MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts. Neurobiol Dis (2002) 0.92
Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry (2012) 0.92
Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study. Int Psychogeriatr (2012) 0.92
Gait and risk of falls associated with frontal cognitive functions at different stages of Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2012) 0.92
A 12 months follow-up study of depression among nursing-home patients in Norway. J Affect Disord (2010) 0.91